NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE · Medical Devices · USD

CONMED Corporation (CNMD) Stock Analysis

CONMED Corporation (CNMD) is a Medical Devices stock listed on NYSE and quoted in US Dollar.

CNMD

$49.32

−$0.10 (−0.20%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare CNMD with… →

CNMD Key Statistics

As of Sep 4, 2026
Trading
Open
$49.09
Previous Close
$49.42
Day's Range
48.61–49.52
52-Week Range
31.44–56.64
Volume
281.30K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.91
Valuation
Market Cap
$1.48B
P/E Ratio
26.80
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
10.31
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.84
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.08
EPS (ttm)Profit attributable to each share over the last twelve months.
1.84
Financials (FY)
Revenue (FY)
$1.37B+5.18%
Net Income (FY)
$47.06M−64.47%
Profit marginThe share of revenue left as profit after all costs and taxes.
4.12%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
29.95M
1-Year Return
−9.48%
Dividend and dates
Dividend
$0.80+1.62%
Ex-Dividend Date
September 15, 2025
Earnings Date
November 4, 2026estimated
Avg Volume
581.78K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

CNMD Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+21.48%
2025−40.03%
2024−36.84%
2023+24.45%
2022−36.98%
2021+27.35%
2020+1.16%
2019+75.71%
2018+27.39%
2017+17.33%
2016 (partial year)+14.23%

As of September 4, 2026.

CNMD Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$1.37B$47.06M3.4%
2024$1.31B$132.42M10.1%
2023$1.24B$64.46M5.2%
2022$1.05B−$80.58M−7.7%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$1.37B$750.48M$102.62M$47.06M3.4%
2024$1.31B$733.03M$200.33M$132.42M10.1%
2023$1.24B$676.25M$120.60M$64.46M5.2%
2022$1.05B$571.25M$70.05M−$80.58M−7.7%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

CNMD Dividend History

$0.60−25.0% vs 2024

Dividends per share, 2025 · 3 payments

YearDividends per sharePaymentsChange
2025$0.603−25.0%
2024$0.804+0.0%
2023$0.804+0.0%
2022$0.804+0.0%
YearDividends per sharePaymentsChange
2025$0.603−25.0%
2024$0.804+0.0%
2023$0.804+0.0%
2022$0.804+0.0%
2021$0.804+0.0%
2020$0.804+0.0%
2019$0.804+0.0%
2018$0.804+0.0%
2017$0.804+100.0%
2016$0.402—

Most recent payment: $0.20 per share, ex-dividend September 15, 2025. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

CNMD Valuation vs Medical Devices Median

Median of 151 stocks
MetricCNMDMedical Devices medianvs median
P/E26.8026.800% above
P/S ratio1.082.9864% below
Profit margin4.12%−1.69%5.8 pts above

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 7 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values CONMED Corporation (CNMD) at $1.48B. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 3,900 employees.

The 52-week range on file runs from $31.44 to $56.64. The most recent close on file for CNMD is $49.32, dated September 4, 2026. That is −$0.10 (−0.20%) against the previous close. The latest close sits 56.87% above that 52-week low.

Financial Health

In fiscal 2025, CONMED Corporation reported revenue of $1.37B. Against the prior fiscal year total of $1.31B, that is a change of +5.18%. The same year closed with net income of $47.06M. That is −64.47% against the prior fiscal year. The reported profit margin is 4.12%. That is 5.8 percentage points above the Medical Devices median of −1.69%. Trailing earnings per share are 1.84.

Across the 4 fiscal years on file, revenue moves from $1.05B in 2022 to $1.37B in 2025. Of those 4 years, 3 report positive net income.

Valuation Assessment

CNMD trades at a trailing price-to-earnings ratio of 26.8. That is 0% above the Medical Devices median of 26.8. On forward earnings the ratio is 10.31. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.84. The price-to-sales ratio is 1.08. On price-to-sales that is 63.81% below the Medical Devices median of 2.98. 151 Medical Devices companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the price has returned −9.48%. Measured over 10 years, that is +2.88% a year compounded. Beta against the wider market is reported at 0.91. Annualized volatility over the trailing 10 years is 39.75%.

Growth & Income

The trailing dividend yield is 1.62%. That is 0.2 percentage points above the Medical Devices median yield of 1.38%. The indicated annual rate is $0.80 a share. The ex-dividend date on file is September 15, 2025. Dividends are recorded for 10 calendar years; 2025 shows 3 payments totalling $0.60 a share. The year before, 2024, totalled $0.80 a share.

So far in 2026 the price is +21.48%. Across the complete calendar years on file, 2019 returned +75.71% and 2025 returned −40.03%. Of the 9 complete calendar years on file, 6 finished higher.

Peer Comparison

CONMED Corporation (CNMD) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
CONMED Corporation CNMD $1.48B 26.8
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. CONMED Corporation trades at a P/E of 26.8.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About CONMED Corporation

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name. In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors, used in minimally invasive surgeries; and electrosurgical solution comprise monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products to treat diseases of dilation, hemostasis, biliary, stricture management, infection prevention, and patient monitoring include ECG electrodes, EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.

Visit website →